One year without dispense
The company also offers testosterone optimization programs, which makes it somewhat unusual in the crowded GLP-1 marketplace
Since semaglutides Indian patent expired in March 2026, generic GLP-1 medications have cut monthly costs by roughly 80%, with prices now starting around 3,0005,000 instead of 10,00011,000
Uncertainties, risks, and limitations The central scenario results set out in Part 2 are based on current best-estimate assumptions for these drugs being used to treat diabetes and weight-loss indications only
In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg